Introduction to asthma and phenotyping.

[1]  W. Calhoun,et al.  Strategies for Molecular Classification of Asthma Using Bipartite Network Analysis of Cytokine Expression , 2012, Current Allergy and Asthma Reports.

[2]  S. Wenzel.  Asthma phenotypes: the evolution from clinical to molecular approaches , 2012, Nature Medicine.

[3]  L. Akinbami,et al.  Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. , 2012, NCHS data brief.

[4]  Mario Castro,et al.  Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. , 2012, American journal of respiratory and critical care medicine.

[5]  Suresh K. Bhavnani,et al.  How cytokines co-occur across asthma patients: From bipartite network analysis to a molecular-based classification , 2011, J. Biomed. Informatics.

[6]  L. Boulet,et al.  Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. , 2011, American journal of respiratory and critical care medicine.

[7]  W. Busse,et al.  Mast cell phenotype, location, and activation in severe asthma. Data from the Severe Asthma Research Program. , 2011, American journal of respiratory and critical care medicine.

[8]  Mario Castro,et al.  Predicting Intermediate Phenotypes in Asthma Using Bronchoalveolar Lavage‐Derived Cytokines , 2010, Clinical and translational science.

[9]  Deborah A Meyers,et al.  Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. , 2010, The Journal of allergy and clinical immunology.

[10]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[11]  I. Adcock,et al.  Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma , 2008, Thorax.

[12]  Mario Castro,et al.  Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. , 2008, The Journal of allergy and clinical immunology.

[13]  I. Pavord,et al.  Association between neutrophilic airway inflammation and airflow limitation in adults with asthma. , 2007, Chest.

[14]  Yee Hwa Yang,et al.  Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids , 2007, Proceedings of the National Academy of Sciences.

[15]  I. Pavord,et al.  Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma , 2007, Thorax.

[16]  J. Bousquet,et al.  Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. , 2007 .

[17]  S. Wenzel.  Phenotypes in asthma: useful guides for therapy, distinct biological processes, or both? , 2004, American journal of respiratory and critical care medicine.

[18]  P. Dorinsky,et al.  Asthma variability in patients previously treated with beta2-agonists alone. , 2003, The Journal of allergy and clinical immunology.

[19]  I. Pavord,et al.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids , 2002, Thorax.

[20]  Diane P. Martin,et al.  Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. , 2002, The Journal of pediatrics.

[21]  Brigit VanGraafeiland,et al.  National Asthma Education and Prevention Program. , 2002, The Nurse practitioner.

[22]  S. Anderson,et al.  The mechanism of exercise-induced asthma is ... , 2000, The Journal of allergy and clinical immunology.

[23]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[24]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[25]  N. Pearce,et al.  How much asthma is really attributable to atopy? , 1999, Thorax.

[26]  S. Anderson,et al.  AIRWAY DRYING AND EXERCISE-INDUCED ASTHMA , 1999 .

[27]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[28]  S. Wenzel,et al.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids. , 1997, American journal of respiratory and critical care medicine.

[29]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[30]  H. Boushey,et al.  The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[31]  C. Randolph,et al.  Exercise-induced asthma: update on pathophysiology, clinical diagnosis, and treatment. , 1997, Current problems in pediatrics.

[32]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[33]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[34]  W. Busse,et al.  Inflammation and asthma. , 1995, Clinics in chest medicine.

[35]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[36]  G. Gleich,et al.  Sudden-onset fatal asthma. , 1994, Mayo Clinic proceedings.

[37]  W. Busse,et al.  Mechanism of airway inflammation in asthma. , 1993, The American review of respiratory disease.

[38]  C E Reed,et al.  Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? , 1993, The American review of respiratory disease.

[39]  J. Virchow,et al.  Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. , 1992, The American review of respiratory disease.

[40]  P. Gergen,et al.  An economic evaluation of asthma in the United States. , 1992, The New England journal of medicine.

[41]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[42]  S. Godfrey,et al.  Exercise-induced asthma as a vascular phenomenon , 1990, The Lancet.

[43]  E. R. Mcfadden,et al.  Exercise-induced airway obstruction. , 1995, Annual review of physiology.

[44]  E. R. Mcfadden,et al.  Exercise-induced asthma. , 1994, The New England journal of medicine.

[45]  S. Godfrey,et al.  The refractory period after exercise-induced asthma: its duration and relation to the severity of exercise. , 2015, The American review of respiratory disease.